Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in Thyroid

Retrieve available abstracts of 298 articles:
HTML format

Single Articles

    May 2022
  1. HATASHIMA A, Archambeau B, Armbruster H, Xu M, et al
    An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma.
    Thyroid. 2022 May 18. doi: 10.1089/thy.2022.0073.
    PubMed     Abstract available

  2. KIM K, Choi JY, Kim SJ, Lee EK, et al
    Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
    Thyroid. 2022 May 16. doi: 10.1089/thy.2021.0679.
    PubMed     Abstract available

    April 2022
  3. TOFT DJ, Schneider AB
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2022.0135.
    PubMed     Abstract available

  4. KIM M, Jin M, Jeon MJ, Kim EY, et al
    Lenvatinib compared with sorafenib as a first-line treatment for radioactive iodinerefractory, progressive, differentiated thyroid carcinoma: Real-world outcomes in a multicenter retrospective cohort study.
    Thyroid. 2022 Apr 20. doi: 10.1089/thy.2022.0054.
    PubMed     Abstract available

  5. CHOU R, Dana T, Brent GA, Goldner W, et al
    Serum Thyroglobulin Measurement Following Surgery without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review.
    Thyroid. 2022 Apr 12. doi: 10.1089/thy.2021.0666.
    PubMed     Abstract available

  6. CAPDEVILA J, Klochikhin A, Leboulleux S, Isaev P, et al
    A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer.
    Thyroid. 2022 Apr 10. doi: 10.1089/thy.2022.0027.
    PubMed     Abstract available

    March 2022
  7. WANG Z, Tang C, Wang Y, Yin Z, et al
    Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified AJCC TNM Staging System.
    Thyroid. 2022 Mar 30. doi: 10.1089/thy.2021.0571.
    PubMed     Abstract available

  8. ZHANG F, Teng D, Tong N, Wang G, et al
    Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study From China.
    Thyroid. 2022 Mar 23. doi: 10.1089/thy.2021.0686.
    PubMed     Abstract available

  9. MA LX, Espin-Garcia O, Bedard PL, Stockley TL, et al
    Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
    Thyroid. 2022 Mar 9. doi: 10.1089/thy.2021.0542.
    PubMed     Abstract available

  10. YEO Y, Shin DW, Han K, Kim D, et al
    Smoking, alcohol consumption, and the risk of thyroid cancer: a population-based Korean cohort study of 10 million people.
    Thyroid. 2022 Mar 2. doi: 10.1089/thy.2021.0675.
    PubMed     Abstract available

  11. MURI R, Trippel M, Borner U, Weidner SE, et al
    The impact of rapid on-site evaluation (ROSE) on the quality and diagnostic value of thyroid nodule fine-needle aspirations.
    Thyroid. 2022 Mar 2. doi: 10.1089/thy.2021.0551.
    PubMed     Abstract available

  12. MATSUURA D, Yuan A, Wang L, Ranganath R, et al
    Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
    Thyroid. 2022;32:245-254.
    PubMed     Abstract available

  13. SIMOES-PEREIRA J, C Ferreira T, Limbert E, Cavaco BM, et al
    Response to "Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries" by Kao.
    Thyroid. 2022;32:342-343.

  14. KAO YH
    Letter to the Editor: Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries.
    Thyroid. 2022;32:340-341.

  15. SUZUKI N, Watanabe N, Noh JY, Yoshimura R, et al
    The relationship between primary thyroid lymphoma and various types of thyroid autoimmunity: A retrospective cohort study of 498 cases, including 9 cases with Graves' disease.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0613.
    PubMed     Abstract available

  16. HOANG JK, Asadollahi S, Durante C, Hegedus L, et al
    An International Survey on Utilization of Five Thyroid Nodule Risk Stratification Systems: A Needs Assessment with Future Implications.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0558.
    PubMed     Abstract available

    February 2022
  17. HSIAO V, Arroyo N, Fernandes-Taylor S, Chiu AS, et al
    Sensitivity of Palpation for Detection of Thyroid Nodules with Attention to Size.
    Thyroid. 2022 Feb 25. doi: 10.1089/thy.2021.0692.
    PubMed     Abstract available

    Impact of Nasolacrimal Dysfunction in Thyroid Cancer Survivors.
    Thyroid. 2022 Feb 18. doi: 10.1089/thy.2022.0095.
    PubMed     Abstract available

  19. GROUSSIN L, Theodon H, Bessiene L, Bricaire L, et al
    Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer.
    Thyroid. 2022 Feb 16. doi: 10.1089/thy.2021.0524.
    PubMed     Abstract available

  20. MEGWALU U, Moon PK
    Thyroid Cancer Incidence and Mortality Trends in the United States: 2000 - 2018.
    Thyroid. 2022 Feb 8. doi: 10.1089/thy.2021.0662.
    PubMed     Abstract available

    January 2022
  21. CHOU R, Dana T, Haymart MR, Leung AM, et al
    Active surveillance versus thyroid surgery for differentiated thyroid cancer: A systematic review.
    Thyroid. 2022 Jan 26. doi: 10.1089/thy.2021.0539.
    PubMed     Abstract available

  22. PASQUAL E, Sosa JA, Chen Y, Schonfeld SJ, et al
    Trends in the management of localized papillary thyroid cancer in the United States (2000-2018).
    Thyroid. 2022 Jan 25. doi: 10.1089/thy.2021.0557.
    PubMed     Abstract available

  23. TCHEKMEDYIAN V, Dunn L, Sherman EJ, Baxi SS, et al
    Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
    Thyroid. 2022 Jan 19. doi: 10.1089/thy.2021.0565.
    PubMed     Abstract available

    Thyroid Disease in Pregnancy: A Touch of Clarity.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0668.
    PubMed     Abstract available

  25. SAWKA AM, Ghai S, Rotstein L, Irish JC, et al
    A quantitative analysis examining patients' choice of active surveillance or surgery for managing low risk papillary thyroid cancer.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0485.
    PubMed     Abstract available

  26. PIERANNUNZIO D, Fedeli U, Francisci S, De Paoli A, et al
    Thyroidectomies in Italy: A population-based national analysis from 2001 to 2018.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0531.
    PubMed     Abstract available

    December 2021
  27. SHOBAB L, Burman KD, Wartofsky L
    Sex Differences in Differentiated Thyroid Cancer.
    Thyroid. 2021 Dec 31. doi: 10.1089/thy.2021.0361.
    PubMed     Abstract available

  28. HESS J, Newbern DK, Beebe KL, Walsh AM, et al
    High prevalence of gene fusions and copy number alterations in pediatric radiation therapy-induced papillary and follicular thyroid carcinomas.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0217.
    PubMed     Abstract available

  29. SHIN A, Cho S, Jang D, Abe SK, et al
    Body mass index and thyroid cancer risk - A pooled analysis of half a million men and women in the Asia Cohort Consortium.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0445.
    PubMed     Abstract available

  30. MEHTA V, Naraparaju A, Liao D, Davies L, et al
    What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0486.
    PubMed     Abstract available

  31. MOLLEN K, Shaffer AD, Yip L, Monaco S, et al
    Unique Molecular Signatures are Associated with Aggressive Histology in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0317.
    PubMed     Abstract available

  32. LIWEN L, Xinguang Q
    Safety and efficacy of ultrasound-guided radiofrequency ablation for benign nonfunctional thyroid nodules in children: a retrospective study of 62 patients with over 4 years of follow-up.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0454.
    PubMed     Abstract available

  33. LEE JY, Woo KI
    Surgical risk prediction for nasolacrimal duct obstruction in radioactive iodine treated thyroid cancer: A nationwide cohort study.
    Thyroid. 2021 Dec 12. doi: 10.1089/thy.2021.0418.
    PubMed     Abstract available

  34. MATSUURA D, Yuan A, Harries V, Shaha AR MD, et al
    Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy.
    Thyroid. 2021 Dec 3. doi: 10.1089/thy.2021.0356.
    PubMed     Abstract available

    November 2021
  35. BISCHOFF L, Haymart MR
    Optimal TSH following lobectomy for papillary thyroid cancer: Does it exist?
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0617.
    PubMed     Abstract available

    The Year in Basic Thyroid Cancer Research.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0561.
    PubMed     Abstract available

    Year in Thyroidology- Recent Developments and Future Challenges: Clinical Science Review.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0562.
    PubMed     Abstract available

  38. JONGEJAN RMS, van Velsen EFS, Meima ME, Klein T, et al
    Change in Thyroid Hormone Metabolite concentrations across Different Thyroid States.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0453.
    PubMed     Abstract available

  39. ROBENSHTOK E, Neeman B, Reches L, Ritter A, et al
    Adverse Histological Features of Differentiated Thyroid Cancer are Commonly Found in Autopsy Studies: Implications for Treatment Guidelines.
    Thyroid. 2021 Nov 13. doi: 10.1089/thy.2021.0268.
    PubMed     Abstract available

  40. SHIMURA H, Matsuzuka T, Suzuki S, Iwadate M, et al
    Fine Needle Aspiration Cytology Implementation and Malignancy Rates in Children and Adolescents Based on Japanese Guidelines: The Fukushima Health Management Survey.
    Thyroid. 2021;31:1683-1692.
    PubMed     Abstract available

    October 2021
  41. BARAN J, Bauer AJ, Halada SJ, Mostoufi-Moab S, et al
    Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0396.
    PubMed     Abstract available

  42. NEWMAN SK, Harries V, Wang LY, McGill MR, et al
    Invasion of a Recurrent Laryngeal Nerve from Small, Well-Differentiated Papillary Thyroid Cancers: Patient Selection Implications for Active Surveillance.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0310.
    PubMed     Abstract available

  43. MONTI S, Presciuttini F, Deiana MG, Motta C, et al
    Cortisol deficiency in Lenvatinib treatment of thyroid cancer: an underestimated, common adverse event.
    Thyroid. 2021 Oct 19. doi: 10.1089/thy.2021.0040.
    PubMed     Abstract available

  44. BERTOL BC, Bales ES, Calhoun JD, Mayberry A, et al
    Lenvatinib plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0371.
    PubMed     Abstract available

  45. PITT SC, Saucke MC, Roman BR, Alexander SC, et al
    The Influence of Emotions on Treatment Decisions about Low-Risk Thyroid Cancer: A Qualitative Study.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0323.
    PubMed     Abstract available

  46. BALLAL S, Yadav MP, Moon ES, Roesch F, et al
    Novel Fibroblast Activation Protein Inhibitor-Based targeted Theranostics for Radioiodine Refractory differentiated Thyroid Cancer Patients: A Pilot Study.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0412.
    PubMed     Abstract available

  47. XU S, Huang Y, Huang H, Zhang X, et al
    Optimal serum thyroid-stimulating hormone level for patients with papillary thyroid carcinoma after lobectomy.
    Thyroid. 2021 Oct 7. doi: 10.1089/thy.2021.0404.
    PubMed     Abstract available

  48. HUANG NS, Wei WJ, Xiang J, Chen JY, et al
    The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-arm Phase II Clinical Trial.
    Thyroid. 2021 Oct 6. doi: 10.1089/thy.2021.0307.
    PubMed     Abstract available

  49. RANA C, Vuong HG, Nguyen TQ, Nguyen HC, et al
    The Incidence of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Meta-Analysis Assessing Worldwide Impact of the Reclassification.
    Thyroid. 2021;31:1502-1513.
    PubMed     Abstract available

    September 2021
  50. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Cutoff age between pediatric and adult thyroid differentiated cancer: Is 18 years old appropriate?
    Thyroid. 2021 Sep 22. doi: 10.1089/thy.2021.0255.
    PubMed     Abstract available

  51. FORLEO R, Grani G, Alfo M, Zilioli V, et al
    Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
    Thyroid. 2021 Sep 19. doi: 10.1089/thy.2021.0248.
    PubMed     Abstract available

  52. SATO A, Tanabe M, Tsuboi Y, Niwa T, et al
    Circulating tumor DNA harboring the BRAF V600E mutation may predict poor outcomes of primary papillary thyroid cancer patients.
    Thyroid. 2021 Sep 19. doi: 10.1089/thy.2021.0267.
    PubMed     Abstract available

  53. DEKKER BL, Muller Kobold AC, Brouwers AH, Williams GRR, et al
    Bone Mineral Density in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma: a longitudinal follow-up study.
    Thyroid. 2021 Sep 13. doi: 10.1089/thy.2021.0179.
    PubMed     Abstract available

  54. GUO K, Qian K, Shi Y, Sun T, et al
    Clinical and Molecular Characterizations of Papillary Thyroid Cancer in Children and Young Adults: a Multicenter Retrospective Study.
    Thyroid. 2021 Sep 13. doi: 10.1089/thy.2021.0003.
    PubMed     Abstract available

    American Thyroid Association Non-Classifiable Thyroid Nodules: A New Perspective.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0449.
    PubMed     Abstract available

  56. MA T, Semsarian CR, Barratt A, Parker L, et al
    Rethinking low risk micropapillary thyroid cancer: an evidence review for recalibrating diagnostic thresholds and/or alternative labels.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0274.
    PubMed     Abstract available

  57. HO AS, Luu M, Shafqat I, Mallen-St Clair J, et al
    Predictive impact of metastatic lymph node burden on distant metastasis across papillary thyroid cancer variants.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0131.
    PubMed     Abstract available

    August 2021
  58. KIM HJ, Chung SM, Kim H, Jang JY, et al
    Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: Results of a 10-year retrospective study.
    Thyroid. 2021 Aug 27. doi: 10.1089/thy.2021.0151.
    PubMed     Abstract available

  59. KOEHLER VF, Berg E, Adam P, Weber GL, et al
    Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer.
    Thyroid. 2021 Aug 18. doi: 10.1089/thy.2021.0091.
    PubMed     Abstract available

  60. GROUSSIN L, Bessiene L, Arrondeau J, Garinet S, et al
    Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer.
    Thyroid. 2021 Aug 18. doi: 10.1089/thy.2021.0144.
    PubMed     Abstract available

  61. XU S, Huang H, Zhang X, Huang Y, et al
    Predictive value of serum thyroglobulin for structural recurrence following lobectomy for papillary thyroid carcinoma.
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0209.
    PubMed     Abstract available

  62. FIGGE JJ, Gooding WE, Steward DL, Yip L, et al
    Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0119.
    PubMed     Abstract available

  63. PIEK MW, de Boer JP, Vriens MR, van Leeuwaarde RS, et al
    Retrospective analyses of 18FDG-PET/CT thyroid incidentaloma in adults: incidence, treatment and outcome in a tertiary cancer referral center.
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0226.
    PubMed     Abstract available

    July 2021
  64. KOBALY K, Kim CS, Langer JE, Mandel SJ, et al
    Macrocalcifications Do Not Alter Malignancy Risk Within the American Thyroid Association Sonographic Pattern System When Present in Non-High Suspicion Thyroid Nodules.
    Thyroid. 2021 Jul 27. doi: 10.1089/thy.2021.0140.
    PubMed     Abstract available

  65. OKAZAKI-HADA M, Maruoka A, Yamamoto M, Ito M, et al
    Poorly differentiated thyroid carcinoma coexisting with Graves' disease involving T3 thyrotoxicosis due to increased D1 and D2 activities.
    Thyroid. 2021 Jul 18. doi: 10.1089/thy.2021.0082.
    PubMed     Abstract available

  66. YAN L, Zhang M, Song Q, Luo Y, et al
    Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-matched Cohort Study of 884 Patients.
    Thyroid. 2021 Jul 16. doi: 10.1089/thy.2021.0100.
    PubMed     Abstract available

  67. JIN M, Kim HI, Ha J, Jeon MJ, et al
    Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
    Thyroid. 2021 Jul 6. doi: 10.1089/thy.2021.0094.
    PubMed     Abstract available

    June 2021
  68. SIMOES-PEREIRA J, C Ferreira T, Limbert E, Cavaco BM, et al
    Outcomes of thyrotropin alfa vs. levothyroxine withdrawal-aided radioiodine therapy for distant metastasis of papillary thyroid cancer.
    Thyroid. 2021 Jun 22. doi: 10.1089/thy.2021.0013.
    PubMed     Abstract available

  69. RYDER M, Wentworth M, Algeciras-Schimnich A, Morris JC 3rd, et al
    Blocking the TSH receptor with K1-70 in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy.
    Thyroid. 2021 Jun 11. doi: 10.1089/thy.2021.0053.
    PubMed     Abstract available

  70. GRONLUND MP, Schmidt Jensen J, Hahn CH, Gronhoj C, et al
    Risk factors for recurrence of follicular thyroid cancer: A systematic review.
    Thyroid. 2021 Jun 9. doi: 10.1089/thy.2020.0921.
    PubMed     Abstract available

  71. EGAN CE, Stefanova D, Ahmed A, Raja VJ, et al
    CSPG4 is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.
    Thyroid. 2021 Jun 3. doi: 10.1089/thy.2021.0067.
    PubMed     Abstract available

    May 2021
  72. BUNEVICIUS A, Fribance S, Pikis S, Lee JYK, et al
    Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
    Thyroid. 2021 May 11. doi: 10.1089/thy.2020.0947.
    PubMed     Abstract available

    April 2021
  73. KIM DH, Kim SW, Kang P, Choi J, et al
    Near-infrared autofluorescence imaging may reduce temporary hypoparathyroidism in patients undergoing total thyroidectomy and central neck dissection.
    Thyroid. 2021 Apr 28. doi: 10.1089/thy.2021.0056.
    PubMed     Abstract available

  74. MARQUES IJ, Gomes I, Pojo M, Pires C, et al
    Identification of SPRY4 as a novel candidate susceptibility gene for familial non-medullary thyroid cancer.
    Thyroid. 2021 Apr 28. doi: 10.1089/thy.2020.0290.
    PubMed     Abstract available

  75. LUBITZ CC, Sadow PM, Daniels GH, Wirth LJ, et al
    Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
    Thyroid. 2021 Apr 16. doi: 10.1089/thy.2020.0962.
    PubMed     Abstract available

  76. VUONG HG, Jung CK, Kakudo K, Bychkov A, et al
    Response to Cherella et al. re: "The use of The Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: a meta-analysis".
    Thyroid. 2021 Apr 15. doi: 10.1089/thy.2021.0190.
    PubMed     Abstract available

  77. LEE SB, Cho YJ, Lee S, Choi YH, et al
    Korean Society of Thyroid Radiology (KSThR) guidelines for the management of pediatric thyroid nodules: Suitability and risk factors.
    Thyroid. 2021 Apr 9. doi: 10.1089/thy.2020.0875.
    PubMed     Abstract available

  78. CHERELLA CE, Cibas ES, Wassner AJ
    Re: "The use of the Bethesda System for Reporting Thyroid Cytopathology in pediatric thyroid nodules - A meta-analysis" by Vuong, et al.
    Thyroid. 2021 Apr 5. doi: 10.1089/thy.2021.0116.
    PubMed     Abstract available

  79. NISHINO M, Mateo R, Kilim H, Feldman A, et al
    Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Thyroid. 2021 Apr 3. doi: 10.1089/thy.2020.0969.
    PubMed     Abstract available

  80. KAYA C, Dorsaint P, Mercurio S, Campbell AM, et al
    Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.
    Thyroid. 2021;31:589-595.
    PubMed     Abstract available

  81. GULEC SA, Ahuja S, Avram A, Bernet V, et al
    Thyroid. 2021 Apr 1. doi: 10.1089/thy.2020.0826.
    PubMed     Abstract available

    March 2021
  82. PAPALEONTIOU M, Chen D, Banerjee M, Reyes-Gastelum D, et al
    TSH Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
    Thyroid. 2021 Mar 27. doi: 10.1089/thy.2021.0033.
    PubMed     Abstract available

  83. GORTAKOWSKI M, Feghali K, Osakwe IN
    Thyroid. 2021 Mar 25. doi: 10.1089/thy.2020.0801.
    PubMed     Abstract available

  84. PAPALEONTIOU M, Norton EC, Reyes-Gastelum D, Banerjee M, et al
    Competing Causes of Death in Older Adults with Thyroid Cancer.
    Thyroid. 2021 Mar 25. doi: 10.1089/thy.2020.0929.
    PubMed     Abstract available

  85. BIBLE KC, Kebebew E, Brierley J, Brito JP, et al
    2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
    Thyroid. 2021;31:337-386.
    PubMed     Abstract available

    February 2021
  86. TAYLOR MH, Takahashi S, Capdevila J, Tahara M, et al
    Correlation of Performance Status and Neutrophil-Lymphocyte Ratio With Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated With Lenvatinib.
    Thyroid. 2021 Feb 26. doi: 10.1089/thy.2020.0779.
    PubMed     Abstract available

  87. QIN YU, Wang JR, Wang Y, Iyer PC, et al
    Clinical Utility of Circulating Cell-free DNA Mutations in Anaplastic Thyroid Carcinoma.
    Thyroid. 2021 Feb 18. doi: 10.1089/thy.2020.0296.
    PubMed     Abstract available

  88. MATHEW A, Latteyer S, Frank-Raue K, Moeller LC, et al
    A Novel Double RET E768D/L790F Mutation Associated with a MEN2B-Like Phenotype.
    Thyroid. 2021;31:327-329.
    PubMed     Abstract available

  89. GRANI G, Zatelli MC, Alfo M, Montesano T, et al
    Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
    Thyroid. 2021;31:264-271.
    PubMed     Abstract available

    January 2021
  90. DIERKS C, Seufert J, Aumann K, Ruf J, et al
    The Lenvatinib/Pembrolizumab combination is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma.
    Thyroid. 2021 Jan 28. doi: 10.1089/thy.2020.0322.
    PubMed     Abstract available

  91. VUONG HGG, Chung DGB, Ngo LM, Bui TQ, et al
    The use of the Bethesda system for reporting thyroid cytopathology in pediatric thyroid nodules - A meta-analysis.
    Thyroid. 2021 Jan 27. doi: 10.1089/thy.2020.0702.
    PubMed     Abstract available

  92. VAN VELSEN EFS, Visser WE, Stegenga MT, Maeder U, et al
    Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    Thyroid. 2021 Jan 23. doi: 10.1089/thy.2020.0615.
    PubMed     Abstract available

  93. MORARIU EM, McCoy KL, Chiosea SI, Nikitski AV, et al
    Clinicopathologic Characteristics of Thyroid Nodules Positive for the THADA-IGF2BP3 Fusion on Preoperative Molecular Analysis.
    Thyroid. 2021 Jan 23. doi: 10.1089/thy.2020.0589.
    PubMed     Abstract available

  94. LONCAR I, van Dijk SPJ, Metman MJH, Lin JF, et al
    Active surveillance for papillary thyroid microcarcinoma in a population with restrictive diagnostic work-up strategies.
    Thyroid. 2021 Jan 11. doi: 10.1089/thy.2020.0845.
    PubMed     Abstract available

    December 2020
  95. CONDELLO V, Nikitski AV, Foulkes W, Nikiforov YE, et al
    Prevalence of WWP1 Gene Mutations in Patients with Thyroid Nodules.
    Thyroid. 2020 Dec 29. doi: 10.1089/thy.2020.0919.
    PubMed     Abstract available

  96. NG DL, van Zante A, Griffin A, Hills NK, et al
    A large thyroid fine needle aspiration biopsy cohort with long-term population-based follow-up.
    Thyroid. 2020 Dec 28. doi: 10.1089/thy.2020.0689.
    PubMed     Abstract available

  97. CORRADO A, Aceto R, Silvestri R, Dell'Anno I, et al
    Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system.
    Thyroid. 2020 Dec 14. doi: 10.1089/thy.2020.0366.
    PubMed     Abstract available

  98. CHUNG SR, Choi YJ, Lee SS, Kim SO, et al
    Interobserver Reproducibility in Sonographic Measurement of Diameter and Volume of Papillary Thyroid Microcarinoma.
    Thyroid. 2020 Dec 7. doi: 10.1089/thy.2020.0317.
    PubMed     Abstract available

  99. TOUMI A, DiGennaro C, Vahdat V, Jalali M, et al
    Trends in Thyroid Surgery and Guideline-Concordant Care in the United States, 2007-2018.
    Thyroid. 2020 Dec 5. doi: 10.1089/thy.2020.0643.
    PubMed     Abstract available

    November 2020
  100. KANG YE, Kim JM, Lim MA, Lee SE, et al
    Growth differentiation factor 15 is a cancer cell-induced mitokine that primes thyroid cancer cells for invasiveness.
    Thyroid. 2020 Nov 30. doi: 10.1089/thy.2020.0034.
    PubMed     Abstract available

  101. SHIH P, Nickel B, Degeling C, Thomas R, et al
    Terminology change for small low-risk papillary thyroid cancer as a response to overtreatment: Results from three Australian community juries.
    Thyroid. 2020 Nov 25. doi: 10.1089/thy.2020.0694.
    PubMed     Abstract available

  102. LORUSSO L, Romei C, Piaggi P, Fustini C, et al
    Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST.
    Thyroid. 2020 Nov 24. doi: 10.1089/thy.2020.0060.
    PubMed     Abstract available

  103. TAIEB D, Castinetti F
    PET imaging in medullary thyroid carcinoma: time for reappraisal?
    Thyroid. 2020 Nov 15. doi: 10.1089/thy.2020.0674.
    PubMed     Abstract available

  104. LANDA I
    PLEKHS1 mutations in thyroid cancers.
    Thyroid. 2020 Nov 15. doi: 10.1089/thy.2020.0728.
    PubMed     Abstract available

  105. CIAPPUCCINI R, Licaj I, Lasne-Cardon A, Babin E, et al
    18F-Fluorocholine PET/CT is a highly sensitive but poorly specific tool for identifying malignancy in thyroid nodules with indeterminate cytology: The Chocolate study.
    Thyroid. 2020 Nov 12. doi: 10.1089/thy.2020.0555.
    PubMed     Abstract available

  106. RAMIREZ-MOYA J, Santisteban P
    A positive feedback loop between DICER1 and differentiation transcription factors is important for thyroid tumorigenesis.
    Thyroid. 2020 Nov 11. doi: 10.1089/thy.2020.0297.
    PubMed     Abstract available

  107. WONG KS, Dong F, Telatar M, Lorch J, et al
    Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome.
    Thyroid. 2020 Nov 4. doi: 10.1089/thy.2020.0668.
    PubMed     Abstract available

  108. BOGDANOVA TI, Saenko VA, Hashimoto Y, Hirokawa M, et al
    Papillary thyroid carcinoma in Ukraine after Chernobyl and in Japan after Fukushima: different histopathological scenarios.
    Thyroid. 2020 Nov 4. doi: 10.1089/thy.2020.0308.
    PubMed     Abstract available

  109. LARCHER DE ALMEIDA AM, Delfim RLC, Vidal APA, Chaves MCDACM, et al
    Combining the American Thyroid Association's ultrasound classification with cytological subcategorization improves the assessment of malignancy risk in indeterminate thyroid nodules.
    Thyroid. 2020 Nov 4. doi: 10.1089/thy.2019.0575.
    PubMed     Abstract available

  110. GUO J, Teng D, Shi X, Li Y, et al
    Exposure to the Chinese Great Famine in early life and thyroid function and disorders in adulthood: a cross-sectional study.
    Thyroid. 2020 Nov 2. doi: 10.1089/thy.2020.0325.
    PubMed     Abstract available

    October 2020
  111. JANMOHAMED N, Segal P, Corrado A, Lofters A, et al
    Endocrinologist perceived factors affecting the transition of thyroid cancer patients from specialist to primary care post-cancer treatment in Ontario, Canada.
    Thyroid. 2020 Oct 29. doi: 10.1089/thy.2020.0413.
    PubMed     Abstract available

  112. KOTWAL A, Erickson D, Geske J, Hay ID, et al
    Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
    Thyroid. 2020 Oct 27. doi: 10.1089/thy.2020.0167.
    PubMed     Abstract available

  113. VALVO V, Iesato A, Kavanagh TR, Priolo C, et al
    Fine-tuning lipid metabolism by targeting mitochondria-associated Acetyl-CoA-Carboxylase 2 in BRAFV600E papillary thyroid carcinoma.
    Thyroid. 2020 Oct 27. doi: 10.1089/thy.2020.0311.
    PubMed     Abstract available

  114. LEE YA, Yun HR, Lee J, Moon H, et al
    Trends in Pediatric Thyroid Cancer Incidence, Treatment, and Clinical Course in Korea during 2004-2016: A Nationwide Population-Based Study.
    Thyroid. 2020 Oct 27. doi: 10.1089/thy.2020.0155.
    PubMed     Abstract available

  115. SUGITANI I, Ito Y, Takeuchi D, Nakayama H, et al
    Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma.
    Thyroid. 2020 Oct 6. doi: 10.1089/thy.2020.0330.
    PubMed     Abstract available

  116. PITT SC, Saucke MC, Wendt EM, Schneider DF, et al
    Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2020.0233.
    PubMed     Abstract available

  117. PIEK MW, Postma EL, van Leeuwaarde R, de Boer JP, et al
    The effect of radioactive iodine therapy on ovarian function and fertility in female thyroid cancer patients: a systematic review and meta-analysis.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2020.0356.
    PubMed     Abstract available

  118. TRAVERSI F, Stooss A, Dettmer MS, Charles RP, et al
    BRAFV600E overrides NOTCH signaling in thyroid cancer.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2019.0595.
    PubMed     Abstract available

    September 2020
  119. GIANI C, Valerio L, Bongiovanni A, Durante C, et al
    Safety and quality of life data from an Italian expanded access program of lenvatinib for treatment of thyroid cancer.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0276.
    PubMed     Abstract available

  120. DEZIEL N, Zhang Y, Wang R, Wiemels J, et al
    Birth Characteristics and Risk of Pediatric Thyroid Cancer: A Population-Based Record-Linkage Study in California.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0217.
    PubMed     Abstract available

  121. YANSONG L, Yang H, Ding Y, Cheng Y, et al
    Donafenib in progressive locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer: results of a randomized, multicenter, phase II trial.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0235.
    PubMed     Abstract available

    August 2020
  122. CHEN D, Reyes-Gastelum D, Veenstra CM, Hamilton AS, et al
    Financial hardship among Hispanic women with thyroid cancer.
    Thyroid. 2020 Aug 25. doi: 10.1089/thy.2020.0497.
    PubMed     Abstract available

  123. JACOBS D, Breen CT, Pucar D, Holt E, et al
    Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer.
    Thyroid. 2020 Aug 18. doi: 10.1089/thy.2020.0237.
    PubMed     Abstract available

  124. SHIN HS, Sun HJ, Whang YM, Park YJ, et al
    Metformin reduces thyroid cancer tumor growth in the metastatic niche of bone by inhibiting osteoblastic RANKL productions.
    Thyroid. 2020 Aug 13. doi: 10.1089/thy.2019.0851.
    PubMed     Abstract available

  125. ZHAO CK, Ren TT, Yin YF, Shi H, et al
    A Comparative Analysis of Two Machine Learning-based Diagnostic Patterns with ACR TI-RADS for Thyroid Nodules: Diagnostic Performance and Unnecessary Biopsy Rate.
    Thyroid. 2020 Aug 11. doi: 10.1089/thy.2020.0305.
    PubMed     Abstract available

  126. KOEHLER V, Adam P, Frank-Raue K, Raue F, et al
    Real world efficacy and safety of cabozantinib and vandetanib in advanced medullary thyroid cancer.
    Thyroid. 2020 Aug 11. doi: 10.1089/thy.2020.0206.
    PubMed     Abstract available

  127. HEGEDUS L, Miyauchi A, Tuttle RM
    Non-surgical thermal ablation of thyroid nodules. Not if, but why, when, and how?
    Thyroid. 2020 Aug 10. doi: 10.1089/thy.2020.0659.
    PubMed     Abstract available

  128. SONG HJ, Chen X, Jiao Q, Qiu ZL, et al
    HIF-1alpha-mediated TERT Activation Inducing Autophagy through mTOR Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress.
    Thyroid. 2020 Aug 9. doi: 10.1089/thy.2020.0023.
    PubMed     Abstract available

  129. ALLOCCA C, Cirafici AM, Laukkanen MO, Castellone MD, et al
    Serine 897 phosphorylation of EPHA2 is involved in signaling of oncogenic ERK1/2 drivers in thyroid cancer cells.
    Thyroid. 2020 Aug 6. doi: 10.1089/thy.2019.0728.
    PubMed     Abstract available

    July 2020
  130. AGATE L, Puleo L, Giani C, Valerio L, et al
    Symptomatic and asymptomatic biliary disorders during lenvatinib treatment for advanced thyroid cancer is an underestimated problem.
    Thyroid. 2020 Jul 29. doi: 10.1089/thy.2020.0245.
    PubMed     Abstract available

  131. MAINO F, Bufano A, Dalmazio G, Campanile M, et al
    Thyroid. 2020 Jul 27. doi: 10.1089/thy.2020.0351.
    PubMed     Abstract available

  132. HERNANDEZ-PRERA J, Valderrabano P, Creed J, de la Iglesia JV, et al
    Thyroid. 2020 Jul 21. doi: 10.1089/thy.2019.0650.
    PubMed     Abstract available

  133. SASAKI T, Miyauchi A, Ito Y, Kudo T, et al
    Marked decrease over time in conversion surgery after active surveillance of low-risk papillary thyroid microcarcinoma.
    Thyroid. 2020 Jul 14. doi: 10.1089/thy.2020.0319.
    PubMed     Abstract available

  134. BRUCE JY, Bible KC, Chintakuntlawar A
    Emergence of resistant clones in medullary thyroid cancer may not be rescued by subsequent salvage highly selective RET-inhibitor therapy.
    Thyroid. 2020 Jul 14. doi: 10.1089/thy.2020.0449.
    PubMed     Abstract available

  135. YOON JH, Hong AR, Kim HK, Kang HC, et al
    Anaplastic Thyroid Cancer Arising from Dyshormonogenetic Goiter: c.3070T>C and Novel c.7070T>C Mutation in the Thyroglobulin Gene.
    Thyroid. 2020 Jul 6. doi: 10.1089/thy.2020.0248.
    PubMed     Abstract available

  136. AHN J, Jin M, Song E, Ryu YM, et al
    Immune profiling of advanced thyroid cancers using fluorescent multiplex immunohistochemistry.
    Thyroid. 2020 Jul 1. doi: 10.1089/thy.2020.0312.
    PubMed     Abstract available

    June 2020
  137. BERNARDI S, Giudici F, Cesareo R, Antonelli G, et al
    Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally-invasive treatments of the thyroid group.
    Thyroid. 2020 Jun 24. doi: 10.1089/thy.2020.0202.
    PubMed     Abstract available

  138. SAWKA AM, Baxter N, Gafni A, Ezzat S, et al
    Response: Letter to Editor "A prospective mixed-methods study of decision-making on surgery or active surveillance for low risk papillary thyroid cancer".
    Thyroid. 2020 Jun 19. doi: 10.1089/thy.2020.0495.
    PubMed     Abstract available

  139. CHUNG R, Guan H, Ponchiardi C, Cerda SR, et al
    Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Epidemiology and Long-Term Outcomes in a Strictly-Defined Cohort.
    Thyroid. 2020 Jun 16. doi: 10.1089/thy.2019.0616.
    PubMed     Abstract available

  140. BIBLE KC, Menefee ME, Lin CC, Millward M, et al
    An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2020 Jun 14. doi: 10.1089/thy.2019.0269.
    PubMed     Abstract available

  141. PARK JH, Choi M, Kim JH, Kim J, et al
    Metabolic syndrome and the risk of thyroid cancer: A nationwide population-based cohort study.
    Thyroid. 2020 Jun 11. doi: 10.1089/thy.2019.0699.
    PubMed     Abstract available

  142. CERIANI L, Milan L, Virili C, Cascione L, et al
    Radiomics analysis of [18F] fluorodeoxyglucose-avid thyroid incidentalomas improves risk stratification and selection for clinical assessment.
    Thyroid. 2020 Jun 10. doi: 10.1089/thy.2020.0224.
    PubMed     Abstract available

  143. CHESOVER AD, Vali R, Hemmati SH, Wasserman JD, et al
    Lung metastasis in children with differentiated thyroid cancer: factors associated with diagnosis and outcomes of therapy.
    Thyroid. 2020 Jun 10. doi: 10.1089/thy.2020.0002.
    PubMed     Abstract available

  144. ZHU CY, Sha SW, Tseng CH, Yang SE, et al
    Trends in the surgical management of known or suspected differentiated thyroid cancer at a single institution, 2010 - 2018.
    Thyroid. 2020 Jun 9. doi: 10.1089/thy.2019.0783.
    PubMed     Abstract available

  145. PEKOVA B, Sykorova V, Dvorakova S, Vaclavikova E, et al
    RET, NTRK, ALK, BRAF and MET fusions in a large cohort of pediatric papillary thyroid carcinomas.
    Thyroid. 2020 Jun 4. doi: 10.1089/thy.2019.0802.
    PubMed     Abstract available

  146. GUGNONI M, Manicardi V, Torricelli F, Sauta E, et al
    Linc00941 is a novel TGFbeta target that primes papillary thyroid cancer metastatic behavior by regulating the expression of Cadherin 6.
    Thyroid. 2020 Jun 4. doi: 10.1089/thy.2020.0001.
    PubMed     Abstract available

  147. YIN N, Sherman SI, Pak Y, Litofsky D, et al
    The De Novo Detection of Anti-thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence.
    Thyroid. 2020 Jun 2. doi: 10.1089/thy.2020.0467.
    PubMed     Abstract available

  148. MIYAUCHI A, Ito Y, Davies L
    "A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer" by Sawka AM et al. (Thyroid 2020 Apr 8. doi: 10.1089/thy.2019.0592. Online ahead of print).
    Thyroid. 2020 Jun 2. doi: 10.1089/thy.2020.0469.
    PubMed     Abstract available

    May 2020
  149. ROSARIO PW, Cortes MC
    Anti-thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence.
    Thyroid. 2020 May 27. doi: 10.1089/thy.2020.0302.
    PubMed     Abstract available

  150. LEE M, Powers AE, Morris LGT, Marti JL, et al
    Reversal in thyroid cancer incidence trends in the United States, 2000-2017.
    Thyroid. 2020 May 27. doi: 10.1089/thy.2020.0321.
    PubMed     Abstract available

  151. TENG D, Li W, Du J, Wang H, et al
    Effects of MWA on Papillary Thyroid Microcarcinoma: A 5-Year Follow-up Report.
    Thyroid. 2020 May 27. doi: 10.1089/thy.2020.0049.
    PubMed     Abstract available

  152. JEON M, You MH, Han JM, Sim SY, et al
    High phosphoglycerate dehydrogenase expression induces stemness and aggressiveness in thyroid cancer.
    Thyroid. 2020 May 22. doi: 10.1089/thy.2020.0105.
    PubMed     Abstract available

  153. SMULEVER A, Barrio Lower Daniele S, Damiano G, Pitoia F, et al
    Complete surgical resection after Dabrafenib plus Trametinib treatment in a patient with locally advanced and metastatic anaplastic thyroid carcinoma with a BRAF V600E mutation.
    Thyroid. 2020 May 12. doi: 10.1089/thy.2020.0251.
    PubMed     Abstract available

  154. HUGHES E, Rhoads A, Thomas A, Aloi J, et al
    Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER18 2000-2016.
    Thyroid. 2020 May 12. doi: 10.1089/thy.2020.0152.
    PubMed     Abstract available

  155. HODAK SP, Duh QY
    The American Association of Endocrine Surgeons (AAES) Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
    Thyroid. 2020 May 10. doi: 10.1089/thy.2020.0209.
    PubMed     Abstract available

  156. CHO SJ, Baek SM, Lim HK, Lee KD, et al
    Long-term Follow-up Results of Ultrasound-guided Radiofrequency Ablation for Low-risk Papillary Thyroid Microcarcinoma: More than 5 year follow-up for 84 tumors.
    Thyroid. 2020 May 7. doi: 10.1089/thy.2020.0106.
    PubMed     Abstract available

  157. HORVATH E, Skoknic Binder V, Majlis Drinberg S, Tala Jury H, et al
    Radioiodine-induced salivary gland damage detected by ultrasonography in patients treated for papillary thyroid cancer: RAI activity and risk.
    Thyroid. 2020 May 6. doi: 10.1089/thy.2019.0563.
    PubMed     Abstract available

  158. KAWANO S, Miyauchi A, Ito Y
    Routine chest CT at presentation does not identify distant metastasis in cT1aN0 papillary thyroid carcinoma.
    Thyroid. 2020 May 5. doi: 10.1089/thy.2020.0073.
    PubMed     Abstract available

  159. AROSEMENA M, Thekkumkattil A, Linares Valderrama MI, Kuker RA, et al
    American Thyroid Association Sonographic Risk and Afirma Gene Expression Classifier Alone and in Combination for the Diagnosis of Thyroid Nodules with Bethesda Category III Cytology.
    Thyroid. 2020 May 2. doi: 10.1089/thy.2019.0673.
    PubMed     Abstract available

    April 2020
  160. FAZELI SR, Zehr B, Amraei R, Toraldo G, et al
    ThyroSeq v2 Testing: Impact on Cytologic Diagnosis, Management, and Cost of Care in Patients with Thyroid Nodule.
    Thyroid. 2020 Apr 29. doi: 10.1089/thy.2019.0191.
    PubMed     Abstract available

  161. CHEN D, Haymart MR
    Disparities research in thyroid cancer: challenges and strategies for improvement.
    Thyroid. 2020 Apr 28. doi: 10.1089/thy.2020.0166.
    PubMed     Abstract available

  162. LEE ZJO, Eslick GD, Edirimanne S
    Investigating anti-thyroglobulin antibody as a prognostic marker for differentiated thyroid cancer: A Meta-Analysis and Systematic Review.
    Thyroid. 2020 Apr 28. doi: 10.1089/thy.2019.0368.
    PubMed     Abstract available

  163. JUNG CK, Jung SH, Jeon S, Jeong YM, et al
    Risk stratification using a novel genetic classifier including <i>PLEKHS1</i> promoter mutations for differentiated thyroid cancer with distant metastasis.
    Thyroid. 2020 Apr 23. doi: 10.1089/thy.2019.0459.
    PubMed     Abstract available

  164. KOTWAL A, Gustafson M, Bornschlegl S, Kottschade L, et al
    Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations.
    Thyroid. 2020 Apr 23. doi: 10.1089/thy.2020.0075.
    PubMed     Abstract available

  165. HALE PM, Ali AK, Buse JB, McCullen MK, et al
    Medullary Thyroid Carcinoma Surveillance Study: a Case-Series Registry.
    Thyroid. 2020 Apr 22. doi: 10.1089/thy.2019.0591.
    PubMed     Abstract available

  166. DIAS-SANTAGATA D, Lennerz JK, Sadow PM, Frazier RP, et al
    Response to RET-Specific Therapy in <i>RET</i> Fusion-Positive Anaplastic Thyroid Carcinoma.
    Thyroid. 2020 Apr 15. doi: 10.1089/thy.2019.0477.
    PubMed     Abstract available

  167. ROTH EM, Lubitz CC, Swan JS, James BC, et al
    Patient-reported quality of life outcome measures in the thyroid cancer population.
    Thyroid. 2020 Apr 15. doi: 10.1089/thy.2020.0038.
    PubMed     Abstract available

  168. XU B, Fuchs TL, Dogan S, Landa I, et al
    Dissecting Anaplastic Thyroid Carcinoma (ATC): A Comprehensive Clinical, histologic, Immunophenotypic, and Molecular Study of 360 Cases.
    Thyroid. 2020 Apr 13. doi: 10.1089/thy.2020.0086.
    PubMed     Abstract available

  169. STEPHENSON A, Eszlinger M, Stewardson P, McIntyre JB, et al
    Sensitive sequencing analysis suggests TSHR and GNAS as sole driver mutations in hot thyroid nodules.
    Thyroid. 2020 Apr 13. doi: 10.1089/thy.2019.0648.
    PubMed     Abstract available

  170. MUIR C, Menzies AM, J Clifton-Bligh R, Tsang VHM, et al
    Thyroid toxicity following immune checkpoint inhibitor treatment in advanced cancer.
    Thyroid. 2020 Apr 7. doi: 10.1089/thy.2020.0032.
    PubMed     Abstract available

  171. CHEN T, Gilfix B, Rivera JA, Sadeghi N, et al
    The Role of the ThyroSeq v3 Molecular Test in the Surgical Management of Thyroid Nodules in the Canadian Public Healthcare Setting.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0539.
    PubMed     Abstract available

  172. POZDEYEV N, Erickson T, Zhang L, Ellison K, et al
    Comprehensive Immune Profiling of Medullary Thyroid Cancer.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0604.
    PubMed     Abstract available

    March 2020
  173. GEMIGNANI F, Romei C, Ciampi R, Corrado A, et al
    Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0352.
    PubMed     Abstract available

  174. LEE YA, Im SW, Jung KC, Chung EJ, et al
    Predominant DICER1 pathogenic Variants in Pediatric Follicular Thyroid Carcinomas.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0233.
    PubMed     Abstract available

  175. FAUSTINO LC, Li CW, Stefan M, Kim K, et al
    A novel mouse model of autoimmune thyroiditis induced by immunization with adenovirus containing full-length thyroglobulin cDNA: Implications to genetic studies of thyroid autoimmunity.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0711.
    PubMed     Abstract available

  176. HONG MJ, Na DG, Lee H
    Diagnostic efficacy and safety of core needle biopsy as a first-line diagnostic method for thyroid nodules: a prospective cohort study.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0444.
    PubMed     Abstract available

  177. ENDO M, Nabhan F, Angell TE, Harrell M, et al
    Use of Molecular Diagnostic Tests in Thyroid Nodules with Hurthle Cell-Dominant Cytology.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2020.0021.
    PubMed     Abstract available

  178. MCKELVEY BA, Gilpatrick T, Wang Y, Timp W, et al
    Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2020.0055.
    PubMed     Abstract available

  179. RAHMAN S, Pandeya N, Neale RE, McLeod DSA, et al
    Obesity is associated with BRAF V600E-mutated thyroid cancer.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0654.
    PubMed     Abstract available

  180. YIN N, Sherman SI, Pak Y, Litofsky D, et al
    The De novo Detection of Anti-thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0791.
    PubMed     Abstract available

  181. CABANILLAS M, Dadu R, Iyer PC, Wanland KB, et al
    Acquired secondary RAS mutation in BRAFV600E mutated thyroid cancer patients treated with BRAF inhibitors.
    Thyroid. 2020 Mar 26. doi: 10.1089/thy.2019.0514.
    PubMed     Abstract available

  182. SUKPANICH R, Sanglestsawai S, Seib CD, Gosnell JE, et al
    The influence of cosmetic concerns on patient preferences for approaches to thyroid lobectomy: A discrete choice experiment.
    Thyroid. 2020 Mar 24. doi: 10.1089/thy.2019.0821.
    PubMed     Abstract available

  183. PEPLAU E, De Rose F, Reder S, Mittelhaeuser M, et al
    Development of a chimeric Fab directed against human galectin-3 and validation as an immune-PET tracer for the sensitive in vivo imaging of thyroid cancer.
    Thyroid. 2020 Mar 21. doi: 10.1089/thy.2019.0670.
    PubMed     Abstract available

  184. PAPALEONTIOU M, Evron J, Esfandiari N, Reyes-Gastelum D, et al
    Patient Report of Recurrent and Persistent Thyroid Cancer.
    Thyroid. 2020 Mar 18. doi: 10.1089/thy.2019.0652.
    PubMed     Abstract available

  185. PAPALEONTIOU M, Haymart MR
    Too much of a good thing? A cautionary tale of thyroid cancer overdiagnosis and overtreatment.
    Thyroid. 2020 Mar 11. doi: 10.1089/thy.2020.0185.
    PubMed     Abstract available

  186. LI H, Wang Z, Liu JS, Zou BS, et al
    Association between breast and thyroid lesions: a cross-sectional study based on ultrasonography screening in China.
    Thyroid. 2020 Mar 8. doi: 10.1089/thy.2019.0184.
    PubMed     Abstract available

  187. AHMADI S, Gonzalez Sepulveda JM, Talbott M, Reed S, et al
    Patient preferences around extent of surgery in low-risk thyroid cancer: A discrete-choice experiment.
    Thyroid. 2020 Mar 6. doi: 10.1089/thy.2019.0590.
    PubMed     Abstract available

  188. SAWKA AM, Ghai S, Yoannidis T, Rotstein L, et al
    A prospective mixed-methods study of decision-making on surgery or active surveillance for low risk papillary thyroid cancer.
    Thyroid. 2020 Mar 4. doi: 10.1089/thy.2019.0592.
    PubMed     Abstract available

  189. YEH T, Yeung M, Sherman EJ, Tuttle RM MD, et al
    Structural doubling time predicts overall survival in patients with medullary thyroid cancer in patients with rapidly progressive metastatic medullary thyroid cancer treated with molecular targeted therapies.
    Thyroid. 2020 Mar 4. doi: 10.1089/thy.2019.0579.
    PubMed     Abstract available

    Targeting Integrins with Radiolabeled RGD Analogs for Radiotheranostics of Metastatic Radioactive Iodine Non-Responsive Thyroid Cancer - New Avenues in Personalized Medicine.
    Thyroid. 2020 Mar 2. doi: 10.1089/thy.2020.0169.
    PubMed     Abstract available

  191. KIM M, Kim SJ, Xu Z, Ha SY, et al
    <i>BRAF<sup>V600E</i></sup> Transduction of SV40-immortalized Normal Human Thyroid Cell Line Induces Dedifferentiated Thyroid Carcinogenesis in a Mouse Xenograft Model.
    Thyroid. 2020 Mar 2. doi: 10.1089/thy.2019.0301.
    PubMed     Abstract available

    February 2020
  192. YIP L
    Thoughtful Utilization of Molecular Testing in Refining Thyroid Nodule Risk Assessment: Don't Throw Out the Baby.
    Thyroid. 2020 Feb 28. doi: 10.1089/thy.2020.0148.
    PubMed     Abstract available

  193. JHIANG SM, Konda B, Sipos JA, Nabhan F, et al
    Prospects for Re-differentiating Agents in the Use of Radioactive Iodine Therapy for Thyroid Cancer.
    Thyroid. 2020 Feb 27. doi: 10.1089/thy.2020.0143.
    PubMed     Abstract available

  194. PEREIRA MM, Williams VL, Hallanger-Johnson JE, Valderrabano P, et al
    Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guidelines' recommendations.
    Thyroid. 2020 Feb 26. doi: 10.1089/thy.2019.0415.
    PubMed     Abstract available

  195. NIES M, Cantineau AEP, Arts EGJM, van den Berg MH, et al
    Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
    Thyroid. 2020 Feb 20. doi: 10.1089/thy.2019.0560.
    PubMed     Abstract available

  196. CHEN JY, Ji QH, Bai C, Zheng X, et al
    Surufatinib in Chinese patients with locally advanced or metastatic differentiated thyroid cancer and medullary thyroid cancer: A multicenter, open-label, Phase II trial.
    Thyroid. 2020 Feb 19. doi: 10.1089/thy.2019.0453.
    PubMed     Abstract available

  197. NIEDERLE MB, Scheuba C, Riss P, Selberherr A, et al
    Early diagnosis of medullary thyroid cancer: Are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays?
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0785.
    PubMed     Abstract available

  198. CESAREO R, Pacella CM, Pasqualini V, Campagna G, et al
    Laser Ablation versus Radiofrequency Ablation for benign non-functioning thyroid nodules: Six-month results of a randomised, parallel, open-label, trial (LARA trial).
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0660.
    PubMed     Abstract available

  199. YEHIA L, Eng C
    The APCs of PTCs: Adenomatous Polyposis Syndrome and the Thyroid.
    Thyroid. 2020 Feb 11. doi: 10.1089/thy.2020.0109.
    PubMed     Abstract available

  200. ZHAO Y, Yu T, Chen L, Xie D, et al
    A Germline <i>CHEK2</i> Mutation in a Family with Papillary Thyroid Cancer.
    Thyroid. 2020 Feb 11. doi: 10.1089/thy.2019.0774.
    PubMed     Abstract available

    Title: Commentary on: "Investigating the effect of thyroid nodule location on the risk of thyroid cancer," Jasim et al. Alternate title: Thyroid nodules and real estate: location matters.
    Thyroid. 2020 Feb 7. doi: 10.1089/thy.2020.0090.
    PubMed     Abstract available

  202. PEREZ-SOTO RH, Velazquez-Fernandez D, Arellano-Gutierrez G, Chapa Ibarguengoitia M, et al
    Preoperative and postoperative risk stratification of thyroid papillary microcarcinoma. A comparative study between Kuma criteria and 2015 ATA guidelines risk stratification.
    Thyroid. 2020 Feb 7. doi: 10.1089/thy.2019.0698.
    PubMed     Abstract available

  203. REN Y, Kyriazidis N, Faquin WC, Soylu S, et al
    The presence of Hurthle cells does not increase the risk of malignancy in most Bethesda categories in thyroid fine-needle aspirates.
    Thyroid. 2020 Feb 4. doi: 10.1089/thy.2019.0190.
    PubMed     Abstract available

  204. THOMAS J, Haertling T
    AIBx, artificial intelligence model to risk stratify thyroid nodules.
    Thyroid. 2020 Feb 4. doi: 10.1089/thy.2019.0752.
    PubMed     Abstract available

    January 2020
  205. GUAN H, Toraldo G, Cerda SR, Godley FA, et al
    Utilities of RAS mutations in pre-operative fine needle biopsies for decision-making for thyroid nodule management: results from a single-center prospective cohort.
    Thyroid. 2020 Jan 29. doi: 10.1089/thy.2019.0116.
    PubMed     Abstract available

  206. SARACYN M, Lubas A, Bober B, Kowalski L, et al
    <b>Recombinant human thyrotropin worsens renal cortical perfusion and renal function in patients after total thyroidectomy due to differentiated thyroid cancer</b>.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0372.
    PubMed     Abstract available

  207. LI M, Brito JP, Vaccarella S
    Long term declines of thyroid cancer mortality: an international age-period-cohort analysis.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0684.
    PubMed     Abstract available

  208. LIU L, Zhang X, Tian T, Huang R, et al
    Prognostic value of pre-ablation stimulated thyroglobulin in children and adolescents with differentiated thyroid cancer.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0585.
    PubMed     Abstract available

  209. GONZALEZ-VELAZQUEZ CD, O'Malley QF, Yue LE, Urken ML, et al
    Letter to the editor: Treatment decisions in thyroid microcarcinomas: Identifying gaps in knowledge to empower our patients.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0451.
    PubMed     Abstract available

  210. PERSICHETTI A, Di Stasio E, Coccaro C, Graziano FM, et al
    Inter- and Intra-Observer Agreement in the Assessment of Thyroid Nodule Ultrasound Features and Classification systems: A Blinded Multicenter Study.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0360.
    PubMed     Abstract available

  211. LEE YK, Hwangbo Y, Lee S, Lee DE, et al
    Aspirin use is not associated with lower thyroid cancer risk: A nationwide nested case-control study.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0641.
    PubMed     Abstract available

    Experience with active surveillance of thyroid microcarcinomalow-risk carcinoma in a developing country.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0522.
    PubMed     Abstract available

  213. JACK GA, Sternberg SB, Aronson MD, Mukamal KJ, et al
    <b>Non-Diagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants</b>.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0140.
    PubMed     Abstract available

  214. PAPARODIS R, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves disease.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0347.
    PubMed     Abstract available

  215. MORENO I, Hirsch D, Duskin-Bitan H, Diker-Cohen T, et al
    Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients- Is rhTSH Stimulation Required?
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0431.
    PubMed     Abstract available

  216. HE H, Li W, Comiskey DF Jr, Liyanarachchi S, et al
    A truncating germline mutation of TINF2 in individuals with thyroid cancer or melanoma results in longer telomeres.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0156.
    PubMed     Abstract available

  217. VAN VELSEN EFS, Visser WE, van den Berg S, Kam BLR, et al
    Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0504.
    PubMed     Abstract available

  218. OH JM, Baek SH, Gangadaran P, Hong CM, et al
    A novel tyrosine kinase inhibitor can augment radioactive iodine uptake through endogenous sodium/iodide symporter (NIS) expression in anaplastic thyroid cancer.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2018.0626.
    PubMed     Abstract available

  219. ZAFEREO M, McIver B, Vargas S, Dominguez Ruiz-Tagle JM, et al
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0490.
    PubMed     Abstract available

  220. ZHANG M, Tufano RP, Russell J, Zhang Y, et al
    Ultrasound-guided radiofrequency ablation versus surgery for low risk papillary thyroid micro-carcinoma: results of over 5 years follow-up.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0147.
    PubMed     Abstract available

  221. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Risk stratification of pediatric patients with differentiated thyroid cancer: Is total thyroidectomy necessary for patients at any risk? .
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0231.
    PubMed     Abstract available

  222. JASIM S, Baranski T, Teefey S, Middleton WD, et al
    Investigating the effect of thyroid nodule location on the risk of thyroid cancer.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0478.
    PubMed     Abstract available

  223. YOSHIDA Y, Horiuchi K, Okamoto T
    Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0420.
    PubMed     Abstract available

  224. JENSEN CB, Saucke MC, Francis DO, Voils CI, et al
    From Overdiagnosis to Overtreatment of Low-risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0587.
    PubMed     Abstract available

    December 2019
  225. YUAN Q, Wu G, Hou J, Liao X, et al
    Correlation between electrophysiological changes and outcomes of vocal cord function in 1764 recurrent laryngeal nerves with visual integrity during thyroidectomy.
    Thyroid. 2019 Dec 27. doi: 10.1089/thy.2019.0361.
    PubMed     Abstract available

  226. PARIHAR AS, Mittal BR, Kumar R, Shukla J, et al
    68Ga-DOTA-RGD2 PET/CT in radioiodine (131I) refractory thyroid cancer - Prospective comparison of diagnostic accuracy with 18F-FDG PET/CT and evaluation towards potential theranostics.
    Thyroid. 2019 Dec 23. doi: 10.1089/thy.2019.0450.
    PubMed     Abstract available

  227. JUN JK, Hwang SY, Hong S, Suh M, et al
    Association of screening by thyroid ultrasonography with mortality in thyroid cancer: a case-control study using data from two national surveys.
    Thyroid. 2019 Dec 23. doi: 10.1089/thy.2019.0460.
    PubMed     Abstract available

  228. MASAKI C, Sugino K, Saito N, Akaishi J, et al
    Efficacy and limitations of lenvatinib therapy for radioiodine-refractory differentiated thyroid cancer: real-world experiences.
    Thyroid. 2019 Dec 19. doi: 10.1089/thy.2019.0221.
    PubMed     Abstract available

  229. NERVO A, Ragni A, Gallo M, Ferraris A, et al
    Thyroid. 2019 Dec 19. doi: 10.1089/thy.2019.0355.
    PubMed     Abstract available

  230. BUSAIDY N
    The Year in Medical Thyroidology Review: Current Challenges and Future Directions.
    Thyroid. 2019 Dec 16. doi: 10.1089/thy.2019.0792.
    PubMed     Abstract available

  231. SAWKA AM, Gagliardi AR, Haymart MR, Sturgeon C, et al
    A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines.
    Thyroid. 2019 Dec 13. doi: 10.1089/thy.2019.0486.
    PubMed     Abstract available

  232. CHENG SY
    The Year in Basic Thyroidology.
    Thyroid. 2019 Dec 10. doi: 10.1089/thy.2019.0768.
    PubMed     Abstract available

  233. CRAIG SJ, Bysice A, Nakoneshny SC, Pasieka JL, et al
    Thyroid. 2019 Dec 6. doi: 10.1089/thy.2019.0274.
    PubMed     Abstract available

  234. CHOI Y, Jung SL
    Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0707.
    PubMed     Abstract available

  235. PARK JL, Jeon S, Seo E, Bae DH, et al
    Comprehensive DNA methylation profiling identifies novel diagnostic biomarkers for thyroid cancer.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0011.
    PubMed     Abstract available

  236. VYDRO L, Kitahara CM, Lubin JH, Schneider AB, et al
    Among Individuals Irradiated for Benign Conditions in Childhood, Developing Thyroid Cancer Does Not Affect All-cause Survival.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0439.
    PubMed     Abstract available

  237. HUILLARD O, Jouinot A, Tlemsani C, Brose MS, et al
    Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial.
    Thyroid. 2019;29:1820-1827.
    PubMed     Abstract available

    November 2019
  238. CHO SJ, Baek JH, Chung SR, Choi YJ, et al
    Thermal ablation for Small Papillary Thyroid Cancer: A Systematic Review.
    Thyroid. 2019 Nov 18. doi: 10.1089/thy.2019.0377.
    PubMed     Abstract available

    October 2019
  239. MASOODI T, Siraj AK, Siraj S, Azam S, et al
    Whole Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer.
    Thyroid. 2019 Oct 31. doi: 10.1089/thy.2019.0052.
    PubMed     Abstract available

  240. ITO Y, Miyauchi A, Kudo T, Higashiyama T, et al
    Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas.
    Thyroid. 2019 Oct 25. doi: 10.1089/thy.2019.0396.
    PubMed     Abstract available

  241. IRAVANI A, Solomon B, Pattison DA, Jackson P, et al
    Mitogen-activated protein kinase pathway inhibition for re-differentiation of radioiodine-refractory differentiated thyroid cancer: an evolving protocol.
    Thyroid. 2019 Oct 22. doi: 10.1089/thy.2019.0143.
    PubMed     Abstract available

  242. CHINTAKUNTLAWAR A, Yin J, Foote RL, Kasperbauer JL, et al
    A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
    Thyroid. 2019 Oct 9. doi: 10.1089/thy.2019.0086.
    PubMed     Abstract available

  243. FUZIWARA CS, Saito KC, Kimura ET
    Thyroid follicular cell loss of differentiation induced by miRNA miR-17-92 cluster is attenuated by CRISPR/Cas9n gene silencing in anaplastic thyroid cancer.
    Thyroid. 2019 Oct 3. doi: 10.1089/thy.2018.0601.
    PubMed     Abstract available

  244. JAIN NK, Mostoufi-Moab S, Hawkes CP, Nelson ND, et al
    Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2019 Oct 1. doi: 10.1089/thy.2019.0229.
    PubMed     Abstract available

    September 2019
  245. IANNI F, Pascucci D, Paragliola RM, Rota CA, et al
    Follow-up or surgery for indeterminate thyroid nodules: could the CUT score application be a support for decision making in the preoperative assessment?
    Thyroid. 2019 Sep 25. doi: 10.1089/thy.2018.0649.
    PubMed     Abstract available

  246. TERROIR M, Caramella C, Borget I, Bidault S, et al
    F-18-Dopa PET/CT is more sensitive than whole body MRI for the localization of persistent/recurrent disease of medullary thyroid cancer patients.
    Thyroid. 2019 Sep 18. doi: 10.1089/thy.2018.0351.
    PubMed     Abstract available

  247. ZAHEDI A, Bondaz L, Rajaraman M, Leslie WD, et al
    Risk for Thyroid Cancer Recurrence Is Higher In Men Than In Women Independent of Disease Stage At Presentation.
    Thyroid. 2019 Sep 16. doi: 10.1089/thy.2018.0775.
    PubMed     Abstract available

  248. MEMON A, Rogers I, Paudyal P, Sundin J, et al
    Dental x-rays and the risk of thyroid cancer and meningioma: A systematic review and meta-analysis of current epidemiological evidence.
    Thyroid. 2019 Sep 10. doi: 10.1089/thy.2019.0105.
    PubMed     Abstract available

  249. LEE EK, Kim SM, Kim BH, Kim MJ, et al
    Lesion-based Evaluation Predicts Treatment Response to Lenvatinib For Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study.
    Thyroid. 2019 Sep 4. doi: 10.1089/thy.2019.0022.
    PubMed     Abstract available

    August 2019
  250. GOLDNER W, Angell TE, McAdoo SL, Babiarz J, et al
    Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2019 Aug 30. doi: 10.1089/thy.2019.0278.
    PubMed     Abstract available

  251. WU D, Ylli D, Heimlich SL, Burman KD, et al
    I-124 PET/CT versus conventional radioiodine imaging in differentiated thyroid cancer: a review.
    Thyroid. 2019 Aug 27. doi: 10.1089/thy.2018.0598.
    PubMed     Abstract available

  252. BULLOCK M, Lim G, Zhu Y, Aberg H, et al
    The ETS Factor ETV5 Activates the Mutant TERT Promoter in Thyroid Cancer.
    Thyroid. 2019 Aug 27. doi: 10.1089/thy.2018.0314.
    PubMed     Abstract available

  253. SUGITANI I, Ito Y, Miyauchi A, Imai T, et al
    Active Surveillance versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-risk Papillary Thyroid Microcarcinoma in Japan.
    Thyroid. 2019 Aug 23. doi: 10.1089/thy.2019.0211.
    PubMed     Abstract available

  254. LEE DH, Kim YK, Yu HW, Choi JY, et al
    Computed Tomography (CT) for Detecting Cervical Lymph Node Metastasis in Patients who have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance.
    Thyroid. 2019 Aug 22. doi: 10.1089/thy.2019.0100.
    PubMed     Abstract available

  255. NICHOLSON K, Roberts MS, McCoy KL, Carty SE, et al
    Molecular Testing Versus Diagnostic Lobectomy in Bethesda III/IV Thyroid Nodules: A Cost-Effectiveness Analysis.
    Thyroid. 2019 Aug 13. doi: 10.1089/thy.2018.0779.
    PubMed     Abstract available

  256. CHO SJ, Suh CH, Baek JH, Chung SR, et al
    Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.
    Thyroid. 2019 Aug 1. doi: 10.1089/thy.2019.0159.
    PubMed     Abstract available

    July 2019
  257. VAN TASSELL B, Wohlford GF, Linderman JD, Smith S, et al
    Pharmacokinetics of Liothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
    Thyroid. 2019 Jul 31. doi: 10.1089/thy.2019.0101.
    PubMed     Abstract available

  258. YOON JH, Lee HS, Kim EK, Moon HJ, et al
    Follow-up strategies for thyroid nodules with benign cytology on US-guided fine needle aspiration: Malignancy rates of management guidelines using US before and after the era of the Bethesda System.
    Thyroid. 2019 Jul 30. doi: 10.1089/thy.2018.0769.
    PubMed     Abstract available

  259. BARROS-FILHO MC, Dos Reis MB, Beltrami CM, de Mello JBH, et al
    DNA methylation-based method to differentiate malignant from benign thyroid lesions.
    Thyroid. 2019 Jul 20. doi: 10.1089/thy.2018.0458.
    PubMed     Abstract available

  260. SHOBAB L, Gomes-Lima CJ, Zeymo A, Feldman R, et al
    Clinical, Pathological and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2019 Jul 18. doi: 10.1089/thy.2019.0075.
    PubMed     Abstract available

  261. NIKIFOROV YE, Nikitski AV, Rominski SL, Condello V, et al
    Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
    Thyroid. 2019 Jul 12. doi: 10.1089/thy.2019.0284.
    PubMed     Abstract available

  262. CHERELLA CE, Angell TE, Richman DM, Frates MC, et al
    Differences in Thyroid Nodule Cytology and Malignancy Risk between Children and Adults.
    Thyroid. 2019 Jul 12. doi: 10.1089/thy.2018.0728.
    PubMed     Abstract available

    June 2019
  263. SIGAL GA, Tavoni T, Silva B, Kalil Filho R, et al
    Response to Dullaart et al., "paper by Sigal GA et al, Thyroid 2019".
    Thyroid. 2019 Jun 25. doi: 10.1089/thy.2019.0384.
    PubMed     Abstract available

  264. PAPALEONTIOU M, Reyes-Gastelum D, Gay BL, Ward KC, et al
    Worry in Thyroid Cancer Survivors with A Favorable Prognosis.
    Thyroid. 2019 Jun 22. doi: 10.1089/thy.2019.0163.
    PubMed     Abstract available

    Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images are Performed Equally.
    Thyroid. 2019 Jun 11. doi: 10.1089/thy.2018.0690.
    PubMed     Abstract available

  266. KONG SH, Ryu J, Kim MJ, Cho SW, et al
    Longitudinal Assessment of Quality of Life According to Treatment Options in Low Risk Papillary Thyroid Microcarcinoma Patients - Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro).
    Thyroid. 2019 Jun 4. doi: 10.1089/thy.2018.0624.
    PubMed     Abstract available

  267. ENDO M, Nabhan F, Porter K, Roll K, et al
    Afirma Gene Sequencing Classifier compared to Gene Expression Classifier in Indeterminate Thyroid Nodules.
    Thyroid. 2019 Jun 1. doi: 10.1089/thy.2018.0733.
    PubMed     Abstract available

    May 2019
  268. ABU-HELALAH M, Alshraideh HA, Al-Sarayreh SA, Al Shawabkeh AH, et al
    A cross-sectional study to assess the prevalence of adult Hypothyroidism and hyperthyroidism in Jordan.
    Thyroid. 2019 May 31. doi: 10.1089/thy.2018.0579.
    PubMed     Abstract available

  269. VAN VELSEN EFS, Stegenga M, van Kemenade FJ, Kam B, et al
    Evaluating the 2015 American Thyroid Association Risk Stratification System in High Risk Papillary and Follicular Thyroid Cancer Patients.
    Thyroid. 2019 May 29. doi: 10.1089/thy.2019.0053.
    PubMed     Abstract available

  270. EDO N, Kawakami K, Fujita Y, Morita K, et al
    Exosomes expressing thyrotropin receptor ameliorate autoantibody-mediated stimulation of cyclic adenosine monophosphate production.
    Thyroid. 2019 May 7. doi: 10.1089/thy.2018.0772.
    PubMed     Abstract available

  271. KOREVAAR T, Haymart MR
    A History of Thyroid Cancer Does Not Meaningfully Complicate Pregnancy.
    Thyroid. 2019 May 2. doi: 10.1089/thy.2019.0276.
    PubMed     Abstract available

  272. DUSKIN-BITAN H, Leibner A, Amitai O, Diker-Cohen T, et al
    Bone-Marrow Suppression in Elderly Patients Following Empiric Radioiodine Therapy: Real-Life Data.
    Thyroid. 2019;29:683-691.
    PubMed     Abstract available

    April 2019
  273. JEON M, Lee YM, Sung TY, Han M, et al
    Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy : A cross-sectional study.
    Thyroid. 2019 Apr 30. doi: 10.1089/thy.2018.0711.
    PubMed     Abstract available

  274. WU D, Gomes Lima CJ, Moreau SL, Kulkarni K, et al
    Improved survival after multimodal approach with 131I treatment in patients with bone metastasis secondary to differentiated thyroid cancer.
    Thyroid. 2019 Apr 24. doi: 10.1089/thy.2018.0582.
    PubMed     Abstract available

  275. STRICKAERT A, Corbet C, Spinette SA, Craciun L, et al
    Reprogramming of energetic metabolism: increased expression and roles of pyruvate carboxylase in papillary thyroid cancer.
    Thyroid. 2019 Apr 16. doi: 10.1089/thy.2018.0435.
    PubMed     Abstract available

  276. CHO GJ, Kim SY, Lee HC, Lee KM, et al
    The risk of adverse obstetric outcomes and the abnormal growth of offspring in women with a history of thyroid cancer.
    Thyroid. 2019 Apr 8. doi: 10.1089/thy.2018.0283.
    PubMed     Abstract available

  277. WANG Y, Liyanarachchi S, Miller KE, Nieminen TT, et al
    Identification of rare variants predisposing to thyroid cancer.
    Thyroid. 2019 Apr 8. doi: 10.1089/thy.2018.0736.
    PubMed     Abstract available

    March 2019
  278. OTSUBO R, Matsuda K, Mussazhanova Z, Sato A, et al
    A novel diagnostic method for thyroid follicular tumors based on immunofluorescence analysis of p53-binding protein 1 expression: detection of genomic instability.
    Thyroid. 2019 Mar 30. doi: 10.1089/thy.2018.0548.
    PubMed     Abstract available

  279. DONG W, Horiuchi K, Tokumitsu H, Sakamoto A, et al
    Time-varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up.
    Thyroid. 2019 Mar 30. doi: 10.1089/thy.2018.0128.
    PubMed     Abstract available

  280. ZHANG B, Tian J, Pei S, Chen Y, et al
    Machine Learning-Assisted System for Thyroid Nodule Diagnosis.
    Thyroid. 2019 Mar 30. doi: 10.1089/thy.2018.0380.
    PubMed     Abstract available

  281. CAO X, Dang L, Zheng X, Lu Y, et al
    Targeting super-enhancer-driven oncogenic transcription by CDK7 inhibition in anaplastic thyroid cancer.
    Thyroid. 2019 Mar 29. doi: 10.1089/thy.2018.0550.
    PubMed     Abstract available

  282. TUTTLE RM MD, Ahuja S, Avram AM, Bernet V, et al
    Controversies, Consensus and Collaboration in the Use of I-131 Therapy in Differentiated Thyroid Cancer.
    Thyroid. 2019 Mar 22. doi: 10.1089/thy.2018.0597.
    PubMed     Abstract available

  283. CAMPENNI A, Trimboli P, Giovanella L
    99mTc-MIBI scan in patients with thyroid nodules: not for everyone but....
    Thyroid. 2019 Mar 20. doi: 10.1089/thy.2018.0712.
    PubMed     Abstract available

  284. HURTADO-LOPEZ LM, Duncker CM
    The use of Tc-99m-Methoxy-Isobutyl-Isonitrile (MIBI) for differentiation of malignant thyroid nodules.
    Thyroid. 2019 Mar 20. doi: 10.1089/thy.2018.0757.
    PubMed     Abstract available

    response letter to paper by Sigal GA et al; Thyroid doi: 10.1089/thy.2018.0190. [Epub ahead of print].
    Thyroid. 2019 Mar 19. doi: 10.1089/thy.2019.0024.
    PubMed     Abstract available

  286. LEBOULLEUX S, Dupuy C, Lacroix L, Attard M, et al
    Redifferentiation of a BRAF-K601E mutated poorly differentiated thyroid cancer patient with dabrafenib and trametinib treatment.
    Thyroid. 2019 Mar 18. doi: 10.1089/thy.2018.0457.
    PubMed     Abstract available

  287. PICCARDO A, Trimboli P, Puntoni M, Foppiani L, et al
    Role of 18F-FCH PET/CT to detect structural relapse in high risk Differentiated Thyroid Cancer patients.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0552.
    PubMed     Abstract available

    February 2019
  288. MAURI G, Pacella CM, Papini E, Solbiati L, et al
    Image-guided Thyroid Ablation: Proposal for Standardization of Terminology and Reporting Criteria.
    Thyroid. 2019 Feb 26. doi: 10.1089/thy.2018.0604.
    PubMed     Abstract available

  289. ANGELL TE, Heller HT, Cibas E, Barletta J, et al
    An independent comparison of the Afirma genomic sequencing classifier (GSC) and gene expression classifier (GEC) for cytologically indeterminate thyroid nodules.
    Thyroid. 2019 Feb 26. doi: 10.1089/thy.2018.0726.
    PubMed     Abstract available

  290. GERON Y, Benbassat C, Steinschneider M, Or K, et al
    Multifocality is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score Matching Analysis.
    Thyroid. 2019 Feb 23. doi: 10.1089/thy.2018.0547.
    PubMed     Abstract available

  291. SHIRAIWA K, Matsuse M, Nakazawa Y, Ogi T, et al
    The JAK/STAT3 and NF-kappaB signaling pathways regulate cancer stem cell properties in anaplastic thyroid cancer cells.
    Thyroid. 2019 Feb 20. doi: 10.1089/thy.2018.0212.
    PubMed     Abstract available

  292. GENUTIS LK, Tomsic J, Bundschuh R, Brock P, et al
    Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
    Thyroid. 2019 Feb 12. doi: 10.1089/thy.2018.0655.
    PubMed     Abstract available

    January 2019
  293. HURST Z, Liyanarachchi S, He H, Brock P, et al
    Risk Haplotypes Uniquely Associated with Radioiodine Refractory Thyroid Cancer Patients of High African Ancestry.
    Thyroid. 2019 Jan 18. doi: 10.1089/thy.2018.0687.
    PubMed     Abstract available

    October 2018
  294. YU CY, Saeed O, Goldberg AS, Farooq S, et al
    A Systematic Review and Meta-analysis of Subsequent Malignant Neoplasm Risk after Radioactive Iodine Treatment of Thyroid Cancer.
    Thyroid. 2018 Oct 27. doi: 10.1089/thy.2018.0244.
    PubMed     Abstract available

  295. SANTOS MT, Buzolin AL, Gama RR, Silva ECA, et al
    Molecular classification of thyroid nodules with indeterminate cytology: development and validation of a highly sensitive and specific new miRNA-based classifier test using fine-needle aspiration smear slides.
    Thyroid. 2018 Oct 15. doi: 10.1089/thy.2018.0254.
    PubMed     Abstract available

  296. CIPRIANI NA, White MG, Angelos P, Grogan RH, et al
    Large Cytologically Benign Thyroid Nodules Do Not Have High Rates of Malignancy or False-Negative Rates and Clinical Observation Should be Considered: A Meta-Analysis.
    Thyroid. 2018 Oct 3. doi: 10.1089/thy.2018.0221.
    PubMed     Abstract available

    September 2018
  297. YU C, Zhang L, Luo D, Yan F, et al
    MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer.
    Thyroid. 2018 Sep 22. doi: 10.1089/thy.2017.0626.
    PubMed     Abstract available

  298. LI Y, Li X, Pu J, Yang Q, et al
    c-Myc is a major determinant for antitumor activity of Aurora A kinase inhibitor MLN8237 in thyroid cancer.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0183.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.